U.S. Biotech Company Ends Sale of Genetic Sequencers in Xinjiang
February 22, 2019
Thermo Fisher Scientific, a leading biotechnology company based in Massachusetts, announced on Thursday that it would no longer sell genetic sequencing equipment in the Chinese region of Xinjiang—referencing “Thermo Fisher’s values, ethics code and policies.” Thermo Fisher’s decision follows widespread concern about use of the equipment for mass surveillance of the region’s Uyghur minority population.
World Day of Social Justice 2019
February 20, 2019
In celebration of , we honor CHR member 's efforts to promote the right to equality and non-discrimination, as former Chair of the Tuskegee Syphilis Study Legacy Committee. Dr. Northington Gamble was instrumental in securing a formal apology from the U.S. government for a decades-long non-therapeutic human experiment involving African American men. Click here to read more about Dr. Northington Gamble’s work to address the legacy of the U.S. Public Health Service Syphilis Study at Tuskegee.